(19)
(11) EP 4 507 736 A1

(12)

(43) Date of publication:
19.02.2025 Bulletin 2025/08

(21) Application number: 23721581.9

(22) Date of filing: 12.04.2023
(51) International Patent Classification (IPC): 
A61K 47/68(2017.01)
A61K 39/395(2006.01)
A61P 35/00(2006.01)
A61K 31/4439(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 45/06; A61K 39/3955; A61K 47/6861; A61K 47/6855; A61K 47/6869; A61K 47/6851; A61K 31/506; A61K 31/706; C07K 16/2818; C07K 2317/76; C07K 16/30; C07K 2317/24; A61K 2039/507; A61K 39/39558; A61K 2039/54; A61K 2039/545; C07K 2317/21; A61K 47/68037
 
C-Sets:
  1. A61K 31/506, A61K 2300/00;
  2. A61K 31/706, A61K 2300/00;
  3. A61K 39/3955, A61K 2300/00;
  4. A61K 39/39558, A61K 2300/00;

(86) International application number:
PCT/US2023/065682
(87) International publication number:
WO 2023/201267 (19.10.2023 Gazette 2023/42)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 13.04.2022 US 202263330700 P
02.08.2022 US 202263370228 P
30.09.2022 US 202263377918 P

(71) Applicants:
  • GILEAD SCIENCES, INC.
    Foster City, California 94404 (US)
  • Arcus Biosciences, Inc.
    Hayward, CA 94545 (US)

(72) Inventors:
  • ABIDOYE, Oyewale
    Atherton, California 94027 (US)
  • CHOU, Chih-Chien
    Foster City, California 94404 (US)
  • GROSSMAN, William J.
    Danville, California 94506 (US)
  • ORF, Jessica N.
    Foster City, California 94404 (US)
  • PARK, Joseph Kwang
    Newbury Park, California 91320 (US)
  • SCHOLLER, Nathalie
    Pacific Grove, California 93950 (US)
  • SIERECKI, Mitchell R.
    Foster City, California 94404 (US)

(74) Representative: Schnappauf, Georg 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) COMBINATION THERAPY FOR TREATING TROP-2 EXPRESSING CANCERS